Gerald R. Melillo Jr.

Gerald R. Melillo Jr. appears in our data through filings on Interpace Biosciences, Inc. shares, published by SEC (Form 4). Between 10 October 2011 and 1 December 2015, the trades on record add up to 11 filings.

On the open market, the record shows 2 purchases worth €13k and 3 sales worth €4,975. Purchases outweigh sales by €7,788. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 6 share grants. Since January 2015: no purchases and 3 sales on the market.

The latest filing, published on 4 December 2015, reports an open-market sale of €3,123 in Interpace Biosciences, Inc. The most recent open-market purchase was published on 12 November 2014, 4,380 days ago. The median gap between a trade and its publication by SEC (Form 4) is 3 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.